Evaluation of quality of oncofertility care in young female cancer patients

Completed

• Conditions: Vruchtbaarheid na oncologische behandeling; Oncofertility care; 10027655

• Registration Number: NL-OMON50410
• Lead Sponsor: Gynaecologie en Obstetrie

Brief Summary

Trial is onging in other countries

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-10-02
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 121

Inclusion Criteria

- Women aged 18-40 years old, cancer diagnosis in 2016 or 2017
- received gonadotoxic treatment
- emotionally and physically able to receive a questionnaire

Exclusion Criteria

- Women who did not receive a gonadotoxic treatment
- patient has had surgery in which her reproductive organs were removed
(ovaries, uterus)
- Not understanding the Dutch or English language

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome measures:<br /><br>Percentage of patients who received information on the risk of infertility and<br /><br>the percentage of women, if desired, who were referred to a gynaecologist.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome measures:<br /><br>Patients experiences with oncofertility care and counseling.<br /><br>Patients' involvement in decision making in fertility preservation.<br /><br>Quality of life<br /><br>Decisional conflict<br /><br>Decisional regret<br /><br>Reproductive concerns.<br /><br>These last four outcomes will be measures by means of validated questionnaires.</p><br>